Search Results

Business

Portal Biotechnologies and Multiply Labs Announce Partnership to Automate Cell Engineering In Cell Therapy Manufacturing

Multiply Labs and Portal Biotechnologies announced their collaboration today, combining the efficiency of Multiply Labs’ robotic automation with the differentiated cell engineering capabilities of the Portal platform.

May 21, 2024

·

4 min read

Press Releases

Answer ALS and Alzheimer’s Disease Data Initiative Announce Partnership to Connect Neuromine Data Portal and AD Workbench

December 5, 2024

·

4 min read

PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy

PharmAla Biotech Holdings Inc. is pleased to announce that it has officially launched its Prescribers Portal for medical practitioners with prescribing power to learn more about MDMA, its effects, and the potential ability to access the molecule for their patients.

May 3, 2024

·

4 min read

Business

Introducing Portal Biotechnologies

Portal Biotechnologies, Inc., a cell engineering platform company, announced its emergence from stealth.

December 12, 2023

·

4 min read

Genetown

Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC

Portal Biotechnologies, Inc., a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital.

March 19, 2024

·

4 min read

Signage at Pfizer's world headquarters in New York City

Business

Pfizer Launches Direct-to-Consumer Portal for Migraine, Flu, COVID-19 Products

The company joins Eli Lilly in offering its own digital platform to more directly connect to patients, allowing them easier access to healthcare providers and prescription drugs.

August 28, 2024

·

2 min read

·

Tristan Manalac

Drug Development

Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH

Galectin Therapeutics, Inc. reported the positive outcome of its fifth independent data and safety monitoring board meeting for NAVIGATE, its seamless, adaptive, Phase 2b/3 study of belapectin in patients with cirrhotic portal hypertension caused by Metabolic Dysfunction-Associated SteatoHepatitis.

April 9, 2024

·

9 min read

Optimi Health and Mind Medicine Australia Launch OptiMed Prescriber Portal for Australian Psychiatrists

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company”), a Health Canada-approved, GMP-compliant pharmaceutical drug manufacturer specializing in the controlled substances MDMA and botanical psilocybin, is pleased to announce the launch of OptiMed

June 27, 2024

·

6 min read

Pharm Country

BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation

BioPharmaSpec, the leading global Contract Research Organization for discovery and preclinical characterization of biopharmaceuticals, has made major new investments in instrumentation, including top-of-the-range Mass Spectrometers, to support its clients in their product development goals.

June 3, 2024

·

1 min read

Genetown

Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook

Bruker Corporation has been selected as the Instrument Business Outlook ‘Company of the Year’ for 2023.

April 1, 2024

·

3 min read